Read more

October 26, 2022
1 min read
Save

Aqueous povidone-iodine or chlorhexidine gluconate may be effective for skin antisepsis

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

TAMPA, Fla. — According to presented results, skin antisepsis for surgical site infection in patients undergoing surgery for an open fracture was effective with both aqueous 10% povidone-iodine and aqueous 4% chlorhexidine gluconate.

“While antiseptic skin solutions of course are an important step to be performed right before surgery, most of the recommendations out there suggest alcohol-based solutions, such as chlorhexidine, should be used,” Gerard Slobogean, MD, MPH, said in his presentation at the Orthopaedic Trauma Association Annual Meeting. “There are no skin prep trials in fracture patients – certainly not in open fracture patients,” he added.

OT1022Slobogean_OTA_Graphic_01
Surgical site infection occurred in 7% (n = 59) of the povidone-iodine group and 7% (n = 58) of the chlorhexidine gluconate group. Data were derived from Slobogean G, et al. Paper 84. Presented at: Orthopaedic Trauma Association Annual Meeting; Oct. 12-15, 2022; Tampa, Fla.

While povidone-iodine has previously been preferred for traumatic contaminated wounds, Slobogean and colleagues in the Preoperative Antiseptic Skin Solutions in Orthopaedic Trauma (PREP-IT) trial set out to test the efficacy of chlorhexidine skin antisepsis in patients with open fractures.

Gerard Slobogean
Gerard Slobogean

From April 8, 2018, to June 8, 2021, the researchers randomized assigned 1,638 patients (mean age of 44.9 years) to either aqueous 10% povidone-iodine (n = 828) or aqueous 4% chlorhexidine gluconate (n = 810) for surgical debridement within 72 hours of an open fracture injury. The primary outcome measure was surgical site infection (SSI), which included incisional infection within 30 days of surgery or deep incisional or organ space infection within 90 days of surgery.

Slobogean and colleagues found similar efficacy between both antisepsis solutions. Of the 1,571 patients with complete outcomes, SSI occurred in 7% (n = 59) of the povidone-iodine group and 7% (n = 58) of the chlorhexidine gluconate group.

“These results are reassuring – reassuring for your own practice and reassuring for other practice environments,” Slobogean said.

“I think that questions some of the transportability of the other prior antiseptic literature that we are basing our practices on,” he added.